Forest Laboratories announced today that the company will discontinue sale of memantine (Namenda) 5-mg and 10-mg tablets effective August 15, 2014, in favor of focusing on sales of its once-daily ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Memantine (Mentadem (10 mg)) is an ...

NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE:FRX), a leading, fully integrated, specialty pharmaceutical company, today announced that it intends to continue to market both its NAMENDA® ...

† Noted adverse events were experienced in ≥5% of either treatment group, and had an incidence more than or equal to twice as great in memantine-treated patients than in placebo-treated patients. AE: ...

MUMBAI, India--(BUSINESS WIRE)--Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted its subsidiary an approval for its ...

United States Food & Drug Administration has granted Ajanta Pharma 10 final approvals and 2 tentative approvals for its abbreviated new drug application, it said, adding another 14 ANDAs are pending ...

According to Business Research Insights the Memantine Hydrochloride Tablets Market expected to exhibit a CAGR of 5.9% by 2033. The "Memantine Hydrochloride Tablets Market" Research is your essential ...

The Tg2576 mouse strain, created by Hsiao et al (1996), was used for these experiments. Tg2576 mice were derived from C57B6/SJL × C57B6 crosses, and contained the double mutation Lys670-Asn, ...

Memantine (Mentadem) is an N-methyl-D-aspartate (NMDA)-receptor antagonist, recommended for Alzheimer's disease. It reduces abnormal activity in the brain, improve the thinking ability and help ...